Australia has a Productivity Problem...so we're told. But as much as we hear it, we rarely hear the magnitude of the problem and what it all means for you? It is easy to think of productivity as doing more work with the same hours. That's kind of true for individual workers, but it is millions…
Let's take a look at Emerging markets for stock investors in Australia to consider. Australians looking to offshore markets may consider the US and New Zealand first, with perhaps Western Europe thereafter.
However, if investors expand their horizons to emerging markets, there's plenty of additional opportunity. Investors can buy these companies directly or can invest in…
Beacon Lighting (ASX:BLX) flies under many investors' radar, but it really shouldn't. The family-owned company sells lights and fans to retail and trade consumers and is the largest company in its industry. It has a proven track record of growth and has more catalysts to come.
Beacon Lighting's track record
Beacon Lighting listed in 2014 at…
Our 5 ASX Predictions for 2025!
Yes it's that time of year. The start of a new one, where everyone gets out their crystal balls and tries to predict what will happen in the year to come. This is no less true with regard to the share market, most particularly the direction of the indices,…
Like it or not, ASX stocks will need to Climate report from 2025. In other words, they will need to include climate-related information in their financial reports. In late March 2024, amendments to the Corporations Act were tabled in parliament, facilitating this.
'A rigorous, internationally‑aligned and credible climate disclosure regime will support Australia’s reputation as an…
Here are the 6 Best American stocks for Australian investors in 2025!
Eli Lilly (NYSE:ELY)
If you thought Novo Nordisk's Ozempic would have all the market to itself...think again. On a market cap basis, it is more than twice the size of Novo Nordisk and is actually the world's largest pharmaceutical company. Like Novo Nordisk,…
Here are our 6 Best ASX Stocks for 2025!
Opthea (ASX:OPT)
Its been a long wait, but 2025 will finally be the year Opthea (ASX:OPT) investors receive Phase 3 results. Opthea is an optometry biotech developing Sozinibercept - a drug fighting wet AMD. Wet AMD is the leading cause of blindness, impacting 3.5m people annually…
5 ASX stocks with the highest PE multiples
Note: All figures are in AUD and for FY25 unless otherwise stated
Polynovo (ASX:PNV) - 154x (Share price of $2.12 vs EPS of $0.01)
PolyNovo is a biotech company behind a technology called NovoSorb. NovoSorb aids recovery in ailments where the body may struggle to rebuild its own…
Here’s everything crucial for Australian investors to know about the Federal Reserve (or ‘The Fed’)!
The first central bank Australian investors will watch is our own RBA, but watching the US Federal Reserve should be second on their list - maybe even first. Actions it takes, from the setting of US interest rates to emergency money in times of crises, have implications not just for the US but the entire…
The term budget blowout has gone viral in the last week. It is not a new term, but it is a term that has been applied to the federal government following the Mid-Year Economic and Fiscal Outlook (MYEFO).
A budget blowout - really?
The underlying cash deficit was actually smaller than had been forecast in the…
